CASP3 and Alzheimer disease: Consistent with these results, as shown in Figure 2D-F, the activity of caspase 3, caspase 9 and the level of Bax in the cortex and hippocampus of AD rats were significantly increased compared with the WT rats and PBM-treated AD rats, supporting the anti-apoptotic efficacy of PBM in AD rats.